Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Forge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Metabiota

Metabiota IPO

$156.11MM
Series B Valuation, Mar 2017
Register for details
For more details on financing and valuation of private companies similar to Metabiota before its M&A, register or log in today.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Log In

Metabiota IPO date and status

2008
Founded
Oct 2022
MA Closed

Company details

Metabiota is a health big data tracking company providing data, analytics, advice, and training to help governments prepare for global health threats and mitigate their impacts.
Founded
2008
Headquarters
San Francisco, CA, United States
Forge Price 1
Price not available
Market Activity 2
Limited
Last Matched Price
Post-Money Valuation 3
$156.11MM
Total Funding
$84.22MM
Last Funding Round
Series B

Learn more about Metabiota

To invest in Metabiota pre-IPO

Can you invest in Metabiota pre-IPO?

You can no longer invest in Metabiota with Forge. But if you are an accredited investor interested in buying pre-IPO shares of a private company, you can learn more about how to invest in the private market or register today to get started.

Can you sell shares of Metabiota before it goes public?

You can no longer sell shares of Metabiota on Forge as this company is no longer private. However, if you own shares of a private company, Forge may be able to help you sell them in a way that works for you and the company. Learn more or register with us today to get started.

What is the pre-IPO value of my Metabiota shares?

Forge can no longer determine the value of Metabiota shares as this company is no longer private. However, if you own shares of a private company, Forge may help you value and sell them in a way that works for you and the company. Learn more or register with us today to get started.

Is Metabiota a publicly traded company?

Metabiota became a public company following its M&A on 10/14/2022 and is now a publicly traded company.

To learn more about Metabiota potential IPO

Will Metabiota go IPO?

Metabiota became a public company following its M&A on 10/14/2022.

What is Metabiota’s IPO price?

The IPO price of Metabiota is not currently available.

When was Metabiota founded?

Metabiota was founded in 2008.

What is Metabiota funding to date?

Metabiota has raised $84.22MM to date.

Metabiota major investors

Undisclosed

Metabiota pre-IPO valuation and funding rounds

Funding history chart
Funding round and deals details
Funding Date Round Amount Raised Price per Share Post-Money Valuation 3 Key Investors
03/07/2017 Series B $8.02MM $1.84 $156.11MM In-Q-Tel, Sharespost, Wp Global Partners
Price per Share
$ xx.xx
Shares Outstanding
4,358,880
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.3x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
In-Q-Tel, Sharespost, Wp Global Partners
05/21/2015 Series A $31.2MM $1.44 $89MM Capricorn Healthcare, Capricorn Investment Group, Google Ventures, Industry Ventures, Rosemont Seneca Technology Partners, Sharespost, The Data Collective, Wp Global Partners
Price per Share
$ xx.xx
Shares Outstanding
21,603,654
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Capricorn Healthcare, Capricorn Investment Group, Google Ventures, Industry Ventures, Rosemont Seneca Technology Partners, Sharespost, The Data Collective, Wp Global Partners
12/24/2013 Series Seed $2.88MM $0.38 $17MM Rosemont Seneca Technology Partners (Rstp), Tao Venture Capital Partners, The Data Collective & Other Investors
Price per Share
$ xx.xx
Shares Outstanding
7,591,990
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Rosemont Seneca Technology Partners (Rstp), Tao Venture Capital Partners, The Data Collective & Other Investors

Metabiota IPO news and media highlights

Want to know where epidemics are flaring up around the world? Metabiota has the tool for you

In an effort to inform the public of the health risks breaking out all over the world (or just to scare the bejeezus out of already paranoid people), the startup Metabiota has released a free-to-use epidemic tracker for all of the outbreaks monitored publicly around the world. The San Francisco-bas…

ARC and Metabiota begin parametric outbreak & epidemic insurance pilot | Artemis.bm

The African Risk Capacity (ARC), a parametric sovereign disaster risk insurer for African nations, has begun a pilot with the help of San Francisco based Metabiota to roll-out parametric insurance cover against disease outbreaks and epidemics. The new parametric outbreak & epidemic insurance product has been coming for some time, as ARC looks to expand its remit to cover new risks which will in turn increase the diversification within and efficiency of its sovereign risk pool. Metabiota is a company focused on risk analytics for epidemics and it has just begun the risk modelling work for the new ARC outbreak and epidemic insurance product. The goal is to help African Nations to better plan for and mitigate the risk of infectious disease outbreaks within their countries, providing an insurance product that will pay out rapidly should an outbreak show signs of developing, helped by the use of parametric triggers and backed by global reinsurance capacity. The pilot phase of the

With a new CEO, Metabiota looks to new markets for its epidemic monitoring toolkit

Bill Rossi, the new chief executive officer at Metabiota, believes that (unlikely as it seems) the insurance industry might be the key to stopping epidemic..
Browse More Insights

Private companies exploring an IPO

See which private companies are preparing for the public market. Register to get full access to the latest secondary market pricing data.

Sector: Healthcare
Subsector: Healthcare Providers & Services
Trade Metrics Last Funding Round
Company Forge Price Last Matched Round Post-Money Valuation 3 Price Per Share Amount Raised
VeraDermicsVeraDermicsNot available$ xx.xxSeries C$306.13MM$1.27$151MM
Eikon TherapeuticsEikon TherapeuticsNot available$ xx.xxSeries D$1.57B$5.84$326.93MM
Spyglass PharmaSpyglass PharmaNot available$ xx.xxSeries D$350.04MM$2.33$75MM
Affinia TherapeuticsAffinia TherapeuticsNot available$ xx.xxSeries C$156.61MM$1.62$40MM
OriginOriginNot available$ xx.xxNot available------

Private market movers

Track trading activity and investor momentum across thousands of private companies. Register to view last matched prices and additional transactional details.

Actively traded

Company Forge Price Market Activity Last Matched
Anthropic Anthropic $259.14 -$13.84 (5.07%)High $xxx.xx
OpenAI OpenAI $723.12 +$0.12 (0.02%)High $xxx.xx
SpaceX SpaceX $550.00 +$102.77 (22.98%)High $xxx.xx
Anduril Anduril $105.00 -$0.53 (0.50%)High $xxx.xx
Databricks Databricks $197.72 +$0.06 (0.03%)High $xxx.xx

Artificial Intelligence (AI)

Company Forge Price Market Activity Last Matched
Anthropic Anthropic $259.14 -$13.84 (5.07%)High $xxx.xx
OpenAI OpenAI $723.12 +$0.12 (0.02%)High $xxx.xx
Anduril Anduril $105.00 -$0.53 (0.50%)High $xxx.xx
Databricks Databricks $197.72 +$0.06 (0.03%)High $xxx.xx
SambaNova Systems SambaNova Systems $14.74 -$1.36 (8.45%)Medium $xxx.xx

Forge, your trusted partner for pre-IPO insights and Metabiota data

Forge is the trusted platform for buying and selling pre-IPO shares. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

Updated on: Jul 16, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions on Forge.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. Actively traded companies are companies with a high market activity with the highest post-money valuation in the same sector.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.